BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17013723)

  • 21. [Diffuse bile duct papillomatosis: high rate of recurrence and risk of malignant transformation].
    Brönnimann S; Zimmermann A; Baer HU
    Chirurg; 1996 Jan; 67(1):93-7. PubMed ID: 8851683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late recurrence after surgery for cholangiocarcinoma: implications for follow-up?
    Thomas H; Heaton ND
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):544-6. PubMed ID: 18842505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A collision tumor composed of cancers of the bile duct and ampulla of Vater--immunohistochemical analysis of a rare entity of double cancer.
    Hirono S; Tani M; Terasawa H; Kawai M; Ina S; Uchiyama K; Nakamura Y; Kakudo K; Yamaue H
    Hepatogastroenterology; 2008; 55(84):861-4. PubMed ID: 18705284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selective resection of the distal bile duct in a high risk patient with polypoid cancer of the intrapancreatic bile duct].
    Yamamoto E; Makino Y
    Nihon Geka Hokan; 1990 Jul; 59(4):315-22. PubMed ID: 2130795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of intrahepatic cholangiocarcinoma nine years after surgical resection.
    Kitagawa D; Taketomi A; Aishima S; Kuroda Y; Gion T; Shirabe K; Shimada M; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1085-8. PubMed ID: 18705334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathological study on the metastatic routes of bile duct carcinoma].
    Wang S; Han B; Chen Y
    Zhonghua Wai Ke Za Zhi; 1996 Jun; 34(6):352-4. PubMed ID: 9594176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
    Ikeyama T; Nagino M; Oda K; Ebata T; Nishio H; Nimura Y
    Ann Surg; 2007 Dec; 246(6):1052-7. PubMed ID: 18043110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal papillary neoplasm of the bile ducts: the clinical features and surgical outcome of 25 cases.
    Paik KY; Heo JS; Choi SH; Choi DW
    J Surg Oncol; 2008 May; 97(6):508-12. PubMed ID: 18314868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surgical strategies for middle and lower bile duct cancer].
    Endo I; Matsuyama R; Mori R; Taniguchi K; Kumamoto N; Takeda K
    Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):190-4. PubMed ID: 25154237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological appraisal of lines of resection for bile duct carcinoma.
    Ebata T; Watanabe H; Ajioka Y; Oda K; Nimura Y
    Br J Surg; 2002 Oct; 89(10):1260-7. PubMed ID: 12296893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carcinoma of the extrahepatic bile duct in young child--a case report].
    Liao XP; Han MT; Wang MM; Wang XW
    Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):314-5. PubMed ID: 3757753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatment of type IV choledochal cysts.
    Kawarada Y; Das BC; Tabata M; Isaji S
    J Hepatobiliary Pancreat Surg; 2009; 16(5):684-7. PubMed ID: 19370303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for radical resection of middle and distal bile duct cancer.
    Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
    Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic study of cholangiocarcinoma with superficial spread.
    Igami T; Nagino M; Oda K; Nishio H; Ebata T; Yokoyama Y; Shimoyama Y
    Ann Surg; 2009 Feb; 249(2):296-302. PubMed ID: 19212185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucin-producing carcinoma of the cystic duct that caused obstructive jaundice.
    Nemoto A; Goshima H; Yoshimine S; Higashiguchi T; Takagi K; Fujii K; Kato H
    Hepatogastroenterology; 2003; 50(53):1250-4. PubMed ID: 14571711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progressive papillomatosis of the intra- and extrahepatic bile ducts].
    Böttger T; Sorger K; Junginger T
    Chirurg; 1989 Feb; 60(2):110-4. PubMed ID: 2707094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of the combination therapy in early stage of recurrent cholangio celluler carcinoma (CCC)].
    Fujiwara S; Hasuike Y; Fukuchi N; Hayashi N; Kida H; Tsujie M; Yoshida T; Ebisui C; Sakita I; Fujimoto T
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1849-51. PubMed ID: 16315960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of cystic duct carcinoma treated with surgery and adjuvant radiotherapy: a proposal for new classification.
    Kim WC; Lee DH; Ahn SI; Kim JM
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):437-40. PubMed ID: 18193129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abdominal wall recurrence of Hilar bile duct cancer 12 years after a curative resection: report of a case.
    Machimoto T; Doi R; Ogawa K; Masui T; Seo S; Uemoto S
    Surg Today; 2009; 39(1):72-6. PubMed ID: 19132474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer.
    Kaneoka Y; Yamaguchi A; Isogai M
    J Hepatobiliary Pancreat Surg; 2007; 14(2):142-8. PubMed ID: 17384904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.